LEADER 01016nam0 2200301 450 001 000028655 005 20110818113926.0 100 $a20110818d1968----km-y0itaa50------ba 101 0 $aita 102 $aIT 200 1 $a<> uomo$eantropologia tipologica$fErich Przywara$ga cura di Vittorio Mathieu 210 $aMilano$c<> Fabbri$d1968 215 $a547 p.$d25 cm 225 2 $aFilosofi contemporanei$v12 410 0$12001$aFilosofi contemporanei$v12 454 1$12001$aMensch$924991 606 1 $aUomo 676 $a128$v(22. ed.)$9Il genere umano 700 1$aPrzywara,$bErich$0160511 702 1$aMathieu,$bVittorio 801 0$aIT$bUniversità della Basilicata - B.I.A.$gRICA$2unimarc 912 $a000028655 996 $aMensch$924991 997 $aUNIBAS BAS $aLETTERE CAT $aTTM$b30$c20110818$lBAS01$h1139 FMT Z30 -1$lBAS01$LBAS01$mBOOK$1BASA1$APolo Storico-Umanistico$2FMAS$BFondo Masini$3FMas/817/3946$6817/3946$5B817/3946$820110818$f04$FPrestabile Didattica LEADER 05481oam 2200469 450 001 9910483567203321 005 20210626121205.0 010 $a3-030-57915-8 024 7 $a10.1007/978-3-030-57915-9 035 $a(CKB)4900000000508947 035 $a(DE-He213)978-3-030-57915-9 035 $a(MiAaPQ)EBC6468496 035 $a(PPN)253861144 035 $a(EXLCZ)994900000000508947 100 $a20210626d2021 uy 0 101 0 $aeng 135 $aurnn|008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aManagement of muscle invasive bladder cancer /$fSanchia S. Goonewardene [and five others] 205 $a1st ed. 2021. 210 1$aCham, Switzerland :$cSpringer,$d[2021] 210 4$d©2021 215 $a1 online resource (XXXIX, 590 p. 37 illus. in color.) 225 0 $aManagement of urology 300 $aIncludes index. 311 $a3-030-57914-X 327 $a1. Introduction to muscle invasive bladder cancer -- 2. Epidemiology and risk factors in muscle invasive bladder cancer -- 3. The molecular basis of muscle invasive bladder cancer -- 4. Histological variants in MIBC - squamous cell and squamous differentiation -- 5. Histological variants in muscle invasive bladder cancer ? adenocarcinoma -- 6. Histological variants in muscle invasive bladder Cancer - sarcomatoid cancer -- 7. MIBC Carcinosarcoma -- 8. Muscle invasive bladder cancer- small cell -- 9. MIBC plasmacytoid -- 10. MIBC and micropapillary bladder cancer -- 11. MIBC bladder cancer assessment and diagnosis -- 12. A systematic review on blue light cystoscopy in bladder cancer diagnostics -- 13. A systematic review on the staging conundrum in bladder cancer -- 14. Current state of investigations and limitations in muscle invasive bladder cancer -- 15. Risk stratification in bladder cancer -- 16. Preventative measures for those with high risk MIBC -- 17. Bladder cancer risk post pelvic irradiation -- 18. A systematic review on bladder preservation strategies and MIBC -- 19. Partial cystectomy -- 20. Muscle invasive bladder cancer and neoadjuvant chemotherapy -- 21. Controversies in clinical effectiveness of neoadjuvant chemotherapy -- 22. Trimodal therapy in bladder cancer -- 23. Systematic review on trimodal therapy in bladder cancer -- 24. Trimodal therapy - a systematic review -- 25. Reviews related to trimodal therapy for MIBC -- 26. Radical cystectomy lap open robotic -- 27. Prostate sparing cystectomy - a systematic review -- 28. A systematic review on nerve sparing cystoprostatectomy -- 29. MIBC - orthotopic vs ileal conduit -- 30. MIBC - a systematic review on orthotopic neobladder vs. ileal conduit -- 31. MIBC and radical cystectomy in the elderly -- 32. MIBC radical radiotherapy -- 33. MIBC - quality of life with urinary diversion -- 34. Neoadjuvant chemotherapy for muscle invasive bladder cancer -- 35. Muscle invasive bladder cancer and the staging conundrum -- 36. Radical cystectomy outcomes -- 37. Muscle Invasive bladder cancer and neoadjuvant chemotherapy -- 38. Muscle invasive bladder cancer and the staging conundrum -- 39. Physical pre-habilitation prior to radical cystectomy -- 40. Exercise therapy pre surgery -- 41. Patient fitness for surgery -- 42. CPEX testing prior to major urological surgery -- 43. Cardio-pulmonary exercise testing and major urological surgery -- 44. Robotic radical cystectomy and enhanced recovery -- 45. The robotic approach to redo surgery -- 46. Robotic cystectomy and intracorporeal neobladder formation -- 47. Secondary pelvic malignancies and bladder cancer -- 48. Organ sparing cystectomy -- 49. Robotic radical cystectomy -- 50. Robotic cystectomy and intracorporeal stoma formation -- 51. Orthotopic neobladders vs. ileal conduits -- 52. The role of enhanced recovery in robotic cystectomy -- 53. Robotic radical cystectomy and lymph node dissection -- 54. Robotic cystectomy and sentinel node mapping -- 55. Robotic radical cystectomy and intracorporeal stoma formation -- 56. Lap vs open vs robotic cystectomy -- 57. A systematic review on obesity in bladder cancer -- 58. Systematic review results on obesity in bladder cancer -- 59. Reviews on BMI and bladder cancer -- 60. Survivorship Issues in muscle invasive bladder cancer -- 61. Muscle invasive bladder cancer and health related quality of life -- 62. Body image in bladder cancer -- 63. The rationale for neoadjuvant chemotherapy -- 64. Support for partners in bladder cancer. 330 $aThis book provides a systematic review of the management and treatment of this disease. The concise and highly structured chapters feature essential background knowledge and commentary on recent advances within each step of a range of patient pathways. Management of Muscle Invasive Bladder Cancer provides a framework for patients? care based on the research, as well as practically and clinically oriented guidelines. This book is relevant to trainees and practicing urologists and oncologists, in addition to medical professionals involved in the treatment of bladder cancer. 410 0$aManagement of Urology,$x2730-6372 606 $aBladder$xCancer 615 0$aBladder$xCancer. 676 $a616.99462 700 $aGoonewardene$b Sanchia$01228004 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bUtOrBLW 906 $aBOOK 912 $a9910483567203321 996 $aManagement of muscle invasive bladder cancer$92850997 997 $aUNINA LEADER 04135nam 2200673 a 450 001 9910789873503321 005 20230113224133.0 010 $a1-283-39601-7 010 $a9786613396013 010 $a90-04-22642-7 024 7 $a10.1163/9789004226425 035 $a(CKB)2670000000139895 035 $a(EBL)832317 035 $a(OCoLC)769927260 035 $a(SSID)ssj0000575731 035 $a(PQKBManifestationID)11358335 035 $a(PQKBTitleCode)TC0000575731 035 $a(PQKBWorkID)10550600 035 $a(PQKB)11653268 035 $a(MiAaPQ)EBC832317 035 $a(OCoLC)778434351 035 $a(nllekb)BRILL9789004226425 035 $a(Au-PeEL)EBL832317 035 $a(CaPaEBR)ebr10524309 035 $a(CaONFJC)MIL339601 035 $a(PPN)170736415 035 $a(EXLCZ)992670000000139895 100 $a20111024d2012 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 14$aThe coins of Herod $ea modern analysis and die classification /$fDonald T. Ariel, Jean-Philippe Fontanille 210 1$aLeiden :$cBrill,$d2012. 215 $a1 online resource (316 pages) 225 1 $aAncient Judaism and early Christianity =$aArbeiten zur Geschichte des antiken Judentums und des Urchristentums,$x1871-6636 ;$vv. 79 300 $aTwo columns to the page. 311 0 $a90-04-20801-1 320 $aIncludes bibliographical references and index. 327 $tPreliminary Material /$rDonald T. Ariel and Jean-Philippe Fontanille --$tIntroduction /$rDonald T. Ariel and Jean-Philippe Fontanille --$tGold and Silver Coins During Herod?s Reign /$rDonald T. Ariel and Jean-Philippe Fontanille --$tA Typology of Herod?s Coins /$rDonald T. Ariel and Jean-Philippe Fontanille --$tThe Dies and Minting Technology /$rDonald T. Ariel and Jean-Philippe Fontanille --$tThe Location of the Mint or Mints /$rDonald T. Ariel and Jean-Philippe Fontanille --$tThe Iconography /$rDonald T. Ariel and Jean-Philippe Fontanille --$tThe Inscriptions /$rDonald T. Ariel and Jean-Philippe Fontanille --$tHerod?s Coins in Hoards /$rDonald T. Ariel and Jean-Philippe Fontanille --$tHerod Coins in Archaeological Contexts /$rDonald T. Ariel and Jean-Philippe Fontanille --$tGeographical Distribution of Herod?s Coins /$rDonald T. Ariel and Jean-Philippe Fontanille --$tA Relative Chronology of Herod?s Coins /$rDonald T. Ariel and Jean-Philippe Fontanille --$tTowards an Absolute Chronology of Herod?s Coins /$rDonald T. Ariel and Jean-Philippe Fontanille --$tBibliography /$rDonald T. Ariel and Jean-Philippe Fontanille --$tIndex /$rDonald T. Ariel and Jean-Philippe Fontanille --$tPlates 1?96 /$rDonald T. Ariel and Jean-Philippe Fontanille. 330 $aHerod, ruler of Judea at a pivotal time (40?4 BCE) in the region?s history, was Rome?s most famous client king. In this volume, Herod?s coinage benefits from a comprehensive reappraisal. The coins and dies have been thoroughly examined, resulting in innovative iconographic and technological interpretations. Study of the coins? presence in hoards, their archaeological contexts and geographical distribution, together with other typological, epigraphic and numismatic observations, have aided in establishing that all of the types were minted in Jerusalem. A new relative chronology of Herod?s dated and undated coins is the most important by-product of this study. Finally, an attempt is made to peg this seriation to known events within the king?s reign. 410 0$aAncient Judaism and early Christianity ;$v79. 606 $aJewish coins$zPalestine 606 $aJewish numismatics$zPalestine 615 0$aJewish coins 615 0$aJewish numismatics 676 $a737.4095694 686 $aBC 7550$2rvk 686 $aBC 8740$2rvk 700 $aAriel$b Donald T$0317965 701 $aFontanille$b Jean-Philippe$01482973 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910789873503321 996 $aThe coins of Herod$93700936 997 $aUNINA